Bone Cancer Surgery
Conditions
Brief summary
According to the Global Burden of Disease Report, the number of cancer patients worldwide is increasing year by year. In 2023, there were a total of 18.5 million newly confirmed cases of malignant tumors worldwide, and it is expected to grow to 30.5 million cases by 2050. Among them, the number of new cases of malignant tumors of bone and articular cartilage increased by 86.4% from 1990 to 2023. Meanwhile, bone is a particularly common site for tumor metastasis, and almost half of cancer patients are at risk of developing bone metastasis. Surgical resection is the main treatment method for both primary and secondary bone cancer. For patients with bone cancer, the main goal of surgical treatment is to maintain the patient's function and mobility by relieving pain, preventing impending fractures and/or nerve compression, or stabilizing pathological fractures. Surgery for bone cancer often requires extensive exploration, osteotomy, and prosthetic reconstruction, resulting in significant surgical trauma. The incidence of postoperative complications remains high. The occurrence of postoperative complications can increase patient pain, prolong hospitalization time, increase medical costs, and even endanger life. Therefore, reduction of complications and optimizing perioperative management are key issues that urgently need to be addressed in clinical practice.
Detailed description
At present, there is a lack of high-quality evidence-based measures for perioperative management of bone cancer. Previous studies have mainly been retrospective, with common issues such as missing variables, small sample sizes, and single disease types, making it difficult to systematically reveal perioperative pathophysiological patterns and provide reliable evidence for clinical management. Therefore, high-quality prospective studies are urgently needed. Therefore, this study intends to conduct a prospective cohort study of patients undergoing surgery for bone cancer, establish a perioperative database, clarify the incidence of complications, explore the factors related to perioperative complications, and provide evidence-based support for improving perioperative management and patient prognosis.
Interventions
PROCEDUREBone cancer surgery
patients receive surgery based on the doctor's discretion and the consideration of the patients and their family
Sponsors
Second Affiliated Hospital, School of Medicine, Zhejiang University
Study design
Observational model
COHORT
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
ALL
Healthy volunteers
No
Inclusion criteria
1. Clinical diagnosis of bone cancer 2. Scheduled to undergo elective bone cancer resection surgery
Exclusion criteria
1. Unable to comply with follow-up 2. declined participation in the study
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Complication | hospital discharge, an average of 10 days | This includes embolic events, pulmonary complication, wound complication, acute kidney injury, death. Diagnose according to radiologic examination, sign and symptom |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| The rate of perioperative transfusion of allogeneic blood products | hospital discharge, an average of 10 days | This includes blood products such as plasma and platelets, erythrocytes |
| Wound drainage volume | hospital discharge, an average of 10 days | Accumulated postoperative wound drainage volume |
| The coagulation function tests during the perioperative period | hospital discharge, an average of 10 days | This includes thromboelastography result |
| Hemoglobin levels | hospital discharge, an average of 10 days | Hemoglobin levels during hospitalIzation |
| 6-month mortality | 6 months | — |
| 1-year mortality | 1 year | — |
| 2-year mortality | 2 years | — |
| 3-year mortality | 3 years | — |
Countries
China
Outcome results
None listed